Akums Drugs and Pharmaceuticals IPO Trading - Strong Demand and a Decent Margin of Safety
180 Views05 Aug 2024 15:30
Akums Drugs and Pharmaceuticals (0200361D IN) raised around US$222m in its India IPO, after pricing the deal at the top end of the range at INR679/share.
What is covered in the Full Insight:
- Introduction
- Allocation Results
- Demand Dynamics
- Previous Deal Performance
- Valuation and Comparison
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Akums Drugs and Pharmaceuticals IPO Trading - Strong Demand and a Decent Margin of Safety05 Aug 2024
- Akums Drugs and Pharmaceuticals IPO - RHP Updates & Quick Thoughts on Peer Comp and Valuation26 Jul 2024
- Akums Drugs and Pharmaceuticals Pre-IPO - Profitable but Needs to Scale up More24 Jul 2024
- Akums Drugs and Pharmaceuticals Pre-IPO Tearsheet26 Feb 2024
x